Tumor testing for advanced bladder cancer to predict treatment efficacy

The Erasmus Mc Bladder Cancer Centre and VitroScan BV join forces on the EVITA project: “Tumor testing for advanced bladder cancer to predict treatment efficacy” The project was awarded with an Erasmus MC-TKI-LSH Match Call (PPP) allowance.

Project coordinators Dr. Joost Boormans, and Dr. Tahlita Zuiverloon: “Together with our affiliated hospitals we have succeeded to establish regional care paths for patients with MIBC and we believe this has substantially improved the quality of care for our patients. However, we are still in desperate need of reliable predictive tests, which could aid in clinical decision making. We are very pleased with the opportunity to leverage our expertise with that of VitroScan within this important study project.”

Aug 10, 2021